{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:47:39Z","timestamp":1792032459919,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The influence of different hypoglycemic agents on peri-implant variables among type 2 diabetes mellitus patients is still unclear. Therefore, the aim of this study was to assess the radiographic marginal bone loss and clinical parameters around implants in patients using different hypoglycemic agents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective cohort study, the dental implant records of type 2 diabetes mellitus patients who met the inclusion criteria were collected. The patients using only single medication as follows: insulin, metformin, or glucagon-like peptide-1 (GLP-1) drugs, were grouped according to their medication. These patients received implant placement with the same initial status, and all the prosthesis restorations were cement-retained ceramic crowns. The peri-implant marginal bone levels were evaluated by periapical radiographs immediately after implant placement and at 1 and 2-year follow-up visits. The baseline characteristics were compared among groups. The peri-implant radiographic marginal bone loss and clinical parameters were preliminarily compared using the Kruskal\u2013Wallis test, and then the covariates were controlled by covariance analysis. Bonferroni post hoc adjustment test was performed for the multiple comparisons.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After a review of more than 7000 medical records, a total of 150 patients with 308 implants at 1-year follow-up were assessed. The peri-implant marginal bone loss in the GLP-1 drug group was significantly smaller than the insulin group and metformin group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). The radiographic bone loss in the metformin group was higher than the insulin group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Some of these included patients were lost to follow-up. Only 74 patients with 129 implants completed the 2-year follow-up. The radiographic bone loss in the metformin group was still higher than the insulin group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and GLP-1 group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). There was no significant difference in the BOP (+) and the mean PD among groups (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The radiographic variables were not exactly the same among the patients with different hypoglycemic agents at both the 1 and 2-year follow-ups. After ensuring consistency in baseline characteristics, the positive effect of GLP-1 drugs on peri-implant bone remodeling may be no less than insulin or metformin. More studies are needed to verify the direct effect of these drugs on peri-implant bone.<\/jats:p>\n                <jats:p><jats:italic>Clinical trial registration number<\/jats:italic> ChiCTR2000034211 (retrospectively registered).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-021-01583-3","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T15:06:41Z","timestamp":1619536001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical and radiographic variables related to implants with simultaneous grafts among type 2 diabetic patients treated with different hypoglycemic medications: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Shaojie","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"1583_CR1","unstructured":"IDF Diabetes Atlas TEC, IDF DIABETES ATLAS Ninth edition 2019; 2019."},{"key":"1583_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1228-0","volume":"19","author":"I Glurich","year":"2019","unstructured":"Glurich I, Acharya A. Updates from the evidence base examining association between periodontal disease and type 2 diabetes mellitus: current status and clinical relevance. Curr Diabetes Rep. 2019;19:1\u20138.","journal-title":"Curr Diabetes Rep"},{"key":"1583_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/cid.12780","volume":"21","author":"S Zhang","year":"2019","unstructured":"Zhang S, Song S, Wang S, et al. Type 2 diabetes affects postextraction socket healing and influences first-stage implant surgery: a study based on clinical and animal evidence. Clin Implant Dent Relat Res. 2019;21:436\u201345.","journal-title":"Clin Implant Dent Relat Res"},{"key":"1583_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jcpe.12860","volume":"45","author":"N Naenni","year":"2018","unstructured":"Naenni N, Bienz SP, Mu\u00f1oz F, et al. Volumetric changes following ridge preservation or spontaneous healing and early implant placement with simultaneous guided bone regeneration. J Clin Periodontol. 2018;45:484\u201394.","journal-title":"J Clin Periodontol"},{"key":"1583_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MED.0000000000000482","volume":"26","author":"L Chambrone","year":"2019","unstructured":"Chambrone L, Palma LF. Current status of dental implants survival and peri-implant bone loss in patients with uncontrolled type-2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2019;26:219\u201322.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1583_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpor.2019.07.007","volume":"64","author":"S Yamazaki","year":"2020","unstructured":"Yamazaki S, Masaki C, Nodai T, et al. The effects of hyperglycaemia on peri-implant tissues after osseointegration. J Prosthodont Res. 2020;64:217\u201323.","journal-title":"J Prosthodont Res"},{"key":"1583_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2018.11.018","volume":"84","author":"FA Shah","year":"2019","unstructured":"Shah FA, Thomsen P, Palmquist A. Osseointegration and current interpretations of the bone-implant interface. Acta Biomater. 2019;84:1\u201315.","journal-title":"Acta Biomater"},{"key":"1583_CR8","first-page":"e949","volume":"10","author":"MH Hameed","year":"2018","unstructured":"Hameed MH, Khan FR, Ghafoor R, et al. Marginal bone loss around cement and screw-retained fixed implant prosthesis. J Clin Exp Dent. 2018;10:e949\u201354.","journal-title":"J Clin Exp Dent"},{"key":"1583_CR9","doi-asserted-by":"publisher","first-page":"s35","DOI":"10.11607\/jomi.19suppl.g3","volume":"34","author":"T Aghaloo","year":"2019","unstructured":"Aghaloo T, Pi-Anfruns J, Moshaverinia A, et al. The effects of systemic diseases and medications on implant osseointegration: a systematic review. Int J Oral Maxillofac Implants. 2019;34:s35\u201349.","journal-title":"Int J Oral Maxillofac Implants"},{"key":"1583_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/clr.12787","volume":"28","author":"MD Al Amri","year":"2017","unstructured":"Al Amri MD, Abduljabbar TS. Comparison of clinical and radiographic status of platform-switched implants placed in patients with and without type 2 diabetes mellitus: a 24-month follow-up longitudinal study. Clin Oral Implan Res. 2017;28:226\u201330.","journal-title":"Clin Oral Implan Res"},{"key":"1583_CR11","doi-asserted-by":"publisher","first-page":"e12478","DOI":"10.1111\/jicd.12478","volume":"10","author":"VL Lagunov","year":"2019","unstructured":"Lagunov VL, Sun J, George R. Evaluation of biologic implant success parameters in type 2 diabetic glycemic control patients versus healthy patients: a meta-analysis. J Investig Clin Dent. 2019;10:e12478.","journal-title":"J Investig Clin Dent"},{"key":"1583_CR12","doi-asserted-by":"publisher","first-page":"e3100","DOI":"10.1002\/dmrr.3100","volume":"35","author":"E Kalaitzoglou","year":"2019","unstructured":"Kalaitzoglou E, Fowlkes JL, Popescu I, et al. Diabetes pharmacotherapy and effects on the musculoskeletal system. Diabetes Metab Res Rev. 2019;35:e3100.","journal-title":"Diabetes Metab Res Rev"},{"key":"1583_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00125-017-4269-4","volume":"60","author":"B Lecka-Czernik","year":"2017","unstructured":"Lecka-Czernik B. Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017;60:1163\u20139.","journal-title":"Diabetologia"},{"key":"1583_CR14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1080\/10717544.2019.1682719","volume":"26","author":"X Wang","year":"2019","unstructured":"Wang X, Qi F, Xing H, et al. Uniform-sized insulin-loaded PLGA microspheres for improved early-stage peri-implant bone regeneration. Drug Deliv. 2019;26:1178\u201390.","journal-title":"Drug Deliv"},{"key":"1583_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fendo.2019.00075","volume":"10","author":"SP Schiellerup","year":"2019","unstructured":"Schiellerup SP, Skov-Jeppesen K, Windel\u00f8v JA, et al. Gut hormones and their effect on bone metabolism potential drug therapies in future osteoporosis treatment. Front Endocrinol. 2019;10:75.","journal-title":"Front Endocrinol"},{"key":"1583_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.11607\/jomi.5838","volume":"33","author":"Z Ormianer","year":"2018","unstructured":"Ormianer Z, Block J, Matalon S, et al. The Effect of Moderately controlled type 2 diabetes on dental implant survival and peri-implant bone loss: a long-term retrospective study. Int J Oral Maxillofac Implants. 2018;33:389\u201394.","journal-title":"Int J Oral Maxillofac Implants"},{"key":"1583_CR17","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.diabres.2019.107990","volume":"159","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Cao Y, Tao Y, et al. Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pr. 2020;159:107990.","journal-title":"Diabetes Res Clin Pr"},{"key":"1583_CR18","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00198-019-04968-x","volume":"30","author":"K Hidayat","year":"2019","unstructured":"Hidayat K, Du X, Shi BM. Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies. Osteoporosis Int. 2019;30:1923\u201340.","journal-title":"Osteoporosis Int"},{"key":"1583_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.diabres.2017.12.008","volume":"136","author":"JM Gamble","year":"2018","unstructured":"Gamble JM, Donnan JR, Chibrikov E, et al. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: a cohort study. Diabetes Res Clin Pract. 2018;136:159\u201367.","journal-title":"Diabetes Res Clin Pract"},{"key":"1583_CR20","first-page":"7","volume":"15","author":"T Albrektsson","year":"1985","unstructured":"Albrektsson T. Dental implants: a review of clinical approaches. Aust Prosthodont Soc Bull. 1985;15:7\u201325.","journal-title":"Aust Prosthodont Soc Bull"},{"issue":"78","key":"1583_CR21","first-page":"59","volume":"2018","author":"T Kocher","year":"2000","unstructured":"Kocher T, K\u00f6nig J, Borgnakke WS, et al. Periodontal complications of hyperglycemia\/diabetes mellitus: epidemiologic complexity and clinical challenge. Periodontol. 2000;2018(78):59\u201397.","journal-title":"Periodontol"},{"key":"1583_CR22","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s00784-018-2666-9","volume":"23","author":"AC Nicolini","year":"2019","unstructured":"Nicolini AC, Grisa TA, Muniz F, et al. Effect of adjuvant use of metformin on periodontal treatment: a systematic review and meta-analysis. Clin Oral Investig. 2019;23:2659\u201366.","journal-title":"Clin Oral Investig"},{"key":"1583_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fendo.2019.00075","volume":"10","author":"SP Schiellerup","year":"2019","unstructured":"Schiellerup SP, Skov-Jeppesen K, Windel\u00f8v JA, et al. Gut hormones and their effect on bone metabolism: potential drug therapies in future osteoporosis treatment. Front Endocrinol (Lausanne). 2019;10:75.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1583_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.peptides.2017.12.008","volume":"100","author":"G Mabilleau","year":"2018","unstructured":"Mabilleau G, Gobron B, Bouvard B, et al. Incretin-based therapy for the treatment of bone fragility in diabetes mellitus. Peptides. 2018;100:108\u201313.","journal-title":"Peptides"},{"key":"1583_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40519-016-0352-y","volume":"22","author":"V Guglielmi","year":"2017","unstructured":"Guglielmi V, Sbraccia P. GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products. Eating Weight Disorders Stud Anorexia Bulimia Obes. 2017;22:231\u201340.","journal-title":"Eating Weight Disorders Stud Anorexia Bulimia Obes"},{"key":"1583_CR26","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1038\/s41598-017-06712-z","volume":"7","author":"Q Li","year":"2017","unstructured":"Li Q, Lin Y, Wang S, et al. GLP-1 inhibits high-glucose-induced oxidative injury of vascular endothelial cells. Sci Rep. 2017;7:8008.","journal-title":"Sci Rep"},{"key":"1583_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bcpt.12850","volume":"122","author":"M Hansen","year":"2018","unstructured":"Hansen M, Tencerova M, Frolich J, et al. Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on bone cell metabolism. Basic Clin Pharmacol Toxicol. 2018;122:25\u201337.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1583_CR28","doi-asserted-by":"publisher","first-page":"e3168","DOI":"10.1002\/dmrr.3168","volume":"35","author":"L Cheng","year":"2019","unstructured":"Cheng L, Hu Y, Li YY, et al. Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes\/Metab Res Rev. 2019;35:e3168.","journal-title":"Diabetes\/Metab Res Rev"},{"key":"1583_CR29","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s00198-018-4649-8","volume":"29","author":"YS Zhang","year":"2018","unstructured":"Zhang YS, Weng WY, Xie BC, et al. Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials. Osteoporosis Int. 2018;29:2639\u201344.","journal-title":"Osteoporosis Int"},{"key":"1583_CR30","first-page":"5077","volume":"15","author":"B Wen","year":"2018","unstructured":"Wen B, Zhao L, Zhao H, et al. Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis. Exp Ther Med. 2018;15:5077\u201383.","journal-title":"Exp Ther Med"},{"key":"1583_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5783639","volume":"2018","author":"W Shen","year":"2018","unstructured":"Shen W, Kimura K, Ishida M, et al. The glucagon-like peptide-1 receptor agonist exendin-4 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption via inhibition of TNF-\u03b1 expression in macrophages. J Immunol Res. 2018;2018:1\u201310.","journal-title":"J Immunol Res"},{"key":"1583_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fendo.2017.00327","volume":"8","author":"M Pereira","year":"2017","unstructured":"Pereira M, Gohin S, Roux J, et al. Exenatide improves bone quality in a murine model of genetically inherited type 2 diabetes mellitus. Front Endocrinol. 2017;8:327.","journal-title":"Front Endocrinol"},{"key":"1583_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bjoms.2015.05.023","volume":"53","author":"Z Liu","year":"2015","unstructured":"Liu Z, Zhou W, Tangl S, et al. Potential mechanism for osseointegration of dental implants in Zucker diabetic fatty rats. Br J Oral Maxillofac Surg. 2015;53:748\u201353.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1583_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00592-015-0792-2","volume":"52","author":"R Li","year":"2015","unstructured":"Li R, Xu W, Luo S, et al. Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes. Acta Diabetol. 2015;52:1083\u201391.","journal-title":"Acta Diabetol"},{"key":"1583_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bcpt.12672","volume":"120","author":"RH Bortolin","year":"2017","unstructured":"Bortolin RH, Freire NF, Arcaro CA, et al. Anabolic effect of insulin therapy on the bone: osteoprotegerin and osteocalcin up-regulation in streptozotocin-induced diabetic rats. Basic Clin Pharmacol Toxicol. 2017;120:227\u201334.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1583_CR36","doi-asserted-by":"publisher","first-page":"111717","DOI":"10.1016\/j.yexcr.2019.111717","volume":"386","author":"L Jia","year":"2020","unstructured":"Jia L, Xiong Y, Zhang W, et al. Metformin promotes osteogenic differentiation and protects against oxidative stress-induced damage in periodontal ligament stem cells via activation of the Akt\/Nrf2 signaling pathway. Exp Cell Res. 2020;386:111717.","journal-title":"Exp Cell Res"},{"key":"1583_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/picr.PICR_125_18","volume":"10","author":"J Raj","year":"2019","unstructured":"Raj J, Venkatachalam S, Shekoba M, et al. Conventional antidiabetic agents and bone health: a pilot case\u2013control study. Perspect Clin Res. 2019;10:177.","journal-title":"Perspect Clin Res"},{"key":"1583_CR38","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/obr.12885","volume":"20","author":"K Hidayat","year":"2019","unstructured":"Hidayat K, Du X, Wu MJ, et al. The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: systematic review and meta-analysis of observational studies. Obes Rev. 2019;20:1494\u2013503.","journal-title":"Obes Rev"},{"key":"1583_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jdiacomp.2018.04.005","volume":"32","author":"KG Kheniser","year":"2018","unstructured":"Kheniser KG, Polanco Santos CM, Kashyap SR. The effects of diabetes therapy on bone: a clinical perspective. J Diabetes Complicat. 2018;32:713\u20139.","journal-title":"J Diabetes Complicat"},{"key":"1583_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5603\/FM.a2015.0129","volume":"75","author":"GS AbdElAziz","year":"2016","unstructured":"AbdElAziz GS, Ramadan WS, El-Fark MO, et al. The beneficial roles of insulin and parathyroid hormones in the treatment of experimentally induced diabetic osteoporosis in female rats: bone mineral density, morphometric and histological studies. Folia Morphol. 2016;75:341\u201354.","journal-title":"Folia Morphol."},{"key":"1583_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.4239\/wjd.v6.i18.1345","volume":"6","author":"I Kanazawa","year":"2015","unstructured":"Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World J Diabetes. 2015;6:1345.","journal-title":"World J Diabetes"},{"key":"1583_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jor.22288","volume":"31","author":"DN Paglia","year":"2013","unstructured":"Paglia DN, Wey A, Breitbart EA, et al. Effects of local insulin delivery on subperiosteal angiogenesis and mineralized tissue formation during fracture healing. J Orthop Res. 2013;31:783\u201391.","journal-title":"J Orthop Res"},{"key":"1583_CR43","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1002\/jbm.a.36442","volume":"106","author":"B\u00d6 Malekzadeh","year":"2018","unstructured":"Malekzadeh B\u00d6, Erlandsson MC, Tengvall P, et al. Effects of implant-delivered insulin on bone formation in osteoporotic rats. J Biomed Mater Res A. 2018;106:2472\u201380.","journal-title":"J Biomed Mater Res A"},{"key":"1583_CR44","doi-asserted-by":"publisher","first-page":"109216","DOI":"10.1016\/j.biopha.2019.109216","volume":"118","author":"T Jia","year":"2019","unstructured":"Jia T, Wang Y, Zhang J, et al. Cinaciguat in combination with insulin induces a favorable effect on implant osseointegration in type 2 diabetic rats. Biomed Pharmacother. 2019;118:109216.","journal-title":"Biomed Pharmacother"},{"key":"1583_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s13346-016-0354-3","volume":"7","author":"Y Park","year":"2017","unstructured":"Park Y. Novel route of insulin delivery using an implant-mediated drug delivery system. Drug Deliv Transl Re. 2017;7:286\u201391.","journal-title":"Drug Deliv Transl Re"},{"key":"1583_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2478\/v10136-012-0018-7","volume":"11","author":"D Wang","year":"2013","unstructured":"Wang D, Du S, Xu M, et al. Effects of insulin therapy on fracture healing and expression of VEGF in diabetic rats. J Appl Biomed. 2013;11:33\u201340.","journal-title":"J Appl Biomed"},{"key":"1583_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.11607\/jomi.5754","volume":"32","author":"CR Serr\u00e3o","year":"2017","unstructured":"Serr\u00e3o CR, Bastos MF, Cruz DF, et al. Role of metformin in reversing the negative impact of hyperglycemia on bone healing around implants inserted in type 2 diabetic rats. Int J Oral Maxillofac Implants. 2017;32:547\u201354.","journal-title":"Int J Oral Maxillofac Implants"},{"key":"1583_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/GME.0000000000001473","volume":"27","author":"F Lin","year":"2020","unstructured":"Lin F, Pan Y, Zhang Y, et al. The effect of metformin on vertebral marrow fat in postmenopausal women with newly diagnosed type 2 diabetes mellitus. Menopause. 2020;27:326\u201332.","journal-title":"Menopause"},{"key":"1583_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/term.2470","volume":"12","author":"P Wang","year":"2018","unstructured":"Wang P, Ma T, Guo D, et al. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells. J Tissue Eng Regen M. 2018;12:437\u201346.","journal-title":"J Tissue Eng Regen M"},{"key":"1583_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.fertnstert.2019.04.013","volume":"112","author":"S Lingaiah","year":"2019","unstructured":"Lingaiah S, Morin-Papunen L, Risteli J, et al. Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study. Fertil Steril. 2019;112:362\u201370.","journal-title":"Fertil Steril"},{"key":"1583_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1620\/tjem.241.13","volume":"241","author":"Q Gu","year":"2017","unstructured":"Gu Q, Gu Y, Yang H, et al. Metformin enhances osteogenesis and suppresses adipogenesis of human chorionic villous mesenchymal stem cells. Tohoku J Exp Med. 2017;241:13\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"1583_CR52","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1530\/JOE-17-0278","volume":"236","author":"G Mabilleau","year":"2018","unstructured":"Mabilleau G, Pereira M, Chenu C. Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists. J Endocrinol. 2018;236:R29\u201342.","journal-title":"J Endocrinol"},{"key":"1583_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-016-0284-1","volume":"11","author":"S King","year":"2016","unstructured":"King S, Klineberg I, Levinger I, et al. The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placement. Arch Osteoporos. 2016;11:1.","journal-title":"Arch Osteoporos"},{"key":"1583_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-017-0324-x","volume":"102","author":"H Miyake","year":"2018","unstructured":"Miyake H, Kanazawa I, Sugimoto T. Association of bone mineral density, bone turnover markers, and vertebral fractures with all-cause mortality in type 2 diabetes mellitus. Calcified Tissue Int. 2018;102:1\u201313.","journal-title":"Calcified Tissue Int"},{"key":"1583_CR55","first-page":"e24067","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Ba Y, Xing Q, et al. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019;9:e24067.","journal-title":"BMJ Open"},{"key":"1583_CR56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/cid.12636","volume":"20","author":"M Kang","year":"2018","unstructured":"Kang M, Jung U, Cho K, et al. Retrospective radiographic observational study of 1692 Straumann tissue-level dental implants over 10 years, II: marginal bone stability. Clin Implant Dent R. 2018;20:875\u201381.","journal-title":"Clin Implant Dent R"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-021-01583-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T15:07:18Z","timestamp":1619536038000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-021-01583-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1186\/s12903-021-01583-3","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"23 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective cohort study was approved by the Ethics Committee of School of Stomatology, the Fourth Military Medical University (Ethics Approval Number: IRB-REV-2020045) and in compliance with the Helsinki Declaration. All patients were given complete information about the treatment and signed informed consent forms before surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors claim to have no financial interest, either directly or indirectly, in the products or information listed in the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}